Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data

NCT05393245 · clinicaltrials.gov ↗

COMPLETED

Status

19467

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium+Olodaterol
DEVICE: Spiolto Respimat
DRUG: Long-acting muscarinic antagonists (LAMAs)
DRUG: Long-acting β2-agonists (LABAs)

Sponsor

Boehringer Ingelheim